BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37760620)

  • 1. Radiomic Assessment of Radiation-Induced Alterations of Skeletal Muscle Composition in Head and Neck Squamous Cell Carcinoma within the Currently Clinically Defined Optimal Time Window for Salvage Surgery-A Pilot Study.
    Santer M; Riechelmann H; Hofauer B; Schmutzhard J; Freysinger W; Runge A; Gottfried TM; Zelger P; Widmann G; Kranebitter H; Mangesius S; Mangesius J; Kocher F; Dejaco D
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
    Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approximation of head and neck cancer volumes in contrast enhanced CT.
    Dejaco D; Url C; Schartinger VH; Haug AK; Fischer N; Riedl D; Posch A; Riechelmann H; Widmann G
    Cancer Imaging; 2015 Sep; 15():16. PubMed ID: 26419914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
    Nøhr A; Gram SB; Charabi B; Tvedskov JF; Wessel I; Friborg J; Håkansson K; von Buchwald C; Fischer BM; Rasmussen JH
    Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2895-2902. PubMed ID: 31297609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
    Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
    Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.
    Elbers JBW; Veldhuis LI; Bhairosing PA; Smeele LE; Jóźwiak K; van den Brekel MWM; Verheij M; Al-Mamgani A; Zuur CL
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):647-655. PubMed ID: 30673847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
    Yom SS; Machtay M; Biel MA; Sinard RJ; El-Naggar AK; Weber RS; Rosenthal DI
    Am J Clin Oncol; 2005 Aug; 28(4):385-92. PubMed ID: 16062081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
    Wendrich AW; Swartz JE; Bril SI; Wegner I; de Graeff A; Smid EJ; de Bree R; Pothen AJ
    Oral Oncol; 2017 Aug; 71():26-33. PubMed ID: 28688687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection and reconstruction of the carotid artery for head and neck squamous cell carcinoma: a GETTEC study.
    Kim Y; Philouze P; Malard O; Dufour X; Nokovitch L; Céruse P; Zrounba P; Maquet C; Deneuve S
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4515-4523. PubMed ID: 35359184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.
    Grossberg AJ; Chamchod S; Fuller CD; Mohamed AS; Heukelom J; Eichelberger H; Kantor ME; Hutcheson KA; Gunn GB; Garden AS; Frank S; Phan J; Beadle B; Skinner HD; Morrison WH; Rosenthal DI
    JAMA Oncol; 2016 Jun; 2(6):782-9. PubMed ID: 26891703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
    Mollnar S; Pondorfer P; Kasparek AK; Reinisch S; Moik F; Stotz M; Halm M; Szkandera J; Terbuch A; Eisner F; Gerger A; Kapp KS; Partl R; Vasicek S; Weiland T; Pichler M; Stöger H; Thurnher D; Posch F
    Clin Transl Oncol; 2021 Mar; 23(3):543-553. PubMed ID: 32671728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiological detection of extracapsular spread in head and neck squamous cell carcinoma (HNSCC) cervical metastases.
    Url C; Schartinger VH; Riechelmann H; Glückert R; Maier H; Trumpp M; Widmann G
    Eur J Radiol; 2013 Oct; 82(10):1783-7. PubMed ID: 23751931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.
    Büntzel J; Glatzel M; Kuttner K; Weinaug R; Fröhlich D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):4-13. PubMed ID: 11917277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific growth rates calculated from CTs in patients with head and neck squamous cell carcinoma: a retrospective study performed in Austria.
    Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
    BMJ Open; 2019 Feb; 9(2):e025359. PubMed ID: 30782931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
    Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
    Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.
    Kim J; Kim S; Albergotti WG; Choi PA; Kaplan DJ; Abberbock S; Johnson JT; Gildener-Leapman N
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1059-65. PubMed ID: 26447790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.